What question did this study set out to answer?

This study aims to analyze pneumococcal vaccine serotypes among adults with community-acquired pneumonia in Germany.

July 26, 2026PneumoniaOpen Access

Pneumococcal pneumonia in adults – re-emergence of vaccine serotypes: a prospective multicenter cohort study in Germany, 2020–2023

View Full Paper

Ask AI

Bookmark

This study aims to analyze pneumococcal vaccine serotypes among adults with community-acquired pneumonia in Germany.
Prospective multicenter cohort study of adults with community-acquired pneumonia from 2020 to 2023.
Patients provided urine samples for serotype-specific urine antigen detection testing.
Annual trends calculated using cluster-robust generalized linear models.
Overall vaccine-type pneumococcal pneumonia proportion was 5.41% for PCV13, 8.11% for PCV20, and 8.31% for PPV23.
Serotype 3 emerged as the most prevalent with 52 cases.
In patients aged ≥ 60 years, an increasing trend was noted for serotype 3 (OR 1.84, 95% CI 1.01–2.67).

No takes yet. Share an insight, caveat, or question.

Prospective cohort study investigates pneumococcal vaccine serotypes in adults, highlighting implications for vaccination.

Bahrs et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark